Olema Pharmaceuticals, Inc.
Price Action
Technical Summary
CONSOLIDATINGOlema Pharmaceuticals, Inc. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is weak (RS Rating: 26), showing significant lag compared to the market leaders. Earnings contraction of 44% provides fundamental context to the price action. Investors should exercise caution due to high volatility (85% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $10.74 | +18.86% | ABOVE |
| 50 SMA | $12.55 | +1.75% | ABOVE |
| 100 SMA | $15.42 | -17.21% | BELOW |
| 150 SMA | $19.44 | -34.31% | BELOW |
| 200 SMA | $17.26 | -26.01% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is OLMA in an uptrend right now?
OLMA has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.
Is OLMA overbought or oversold?
OLMA's RSI (14) is 60. The stock is in neutral territory, neither overbought nor oversold.
Is OLMA outperforming the market?
OLMA has a Relative Strength (RS) Rating of 26 out of 99. OLMA is currently lagging the broader market.
Where is OLMA in its 52-week range?
OLMA is trading at $12.77, which is 35% of its 52-week high ($36.13) and 26% above its 52-week low ($4.37).
How volatile is OLMA?
OLMA has a Beta of 1.05 and 52-week volatility of 85%. It's more volatile than the S&P 500 - expect bigger swings.